Taylor Financial Group »

Candel Therapeutics shares owned by Taylor Financial Group

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Taylor Financial Group from 13F filings

Historical chart of Taylor Financial Group investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Taylor Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Taylor Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $69k 14k 5.10
2025-06-30 $51k 10k 5.06
2025-03-31 $57k 10k 5.65

More positions owned by Taylor Financial Group

Vanguard Index Fds Growth Etf (VUG)
Norfolk Southern (NSC)
Oracle Corporation (ORCL)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Select Divid Etf (DVY)
Microsoft Corporation (MSFT)
Ishares Tr Core Divid Etf (DIVB)
Capital Group Core Balanced SHS (CGBL)
Fiserv (FI)
Ssga Active Etf Tr Globl Allo Etf (GAL)
Home Depot (HD)
Ishares Tr Core 40/60 Moder (AOM)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Taylor Financial Group

Top funds holding Candel Therapeutics

FMR
Acorn Capital Advisors
BlackRock
Vanguard Group
Portolan Capital Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Citadel Advisors
Sands Capital Ventures
Susquehanna International
Northern Trust
Nuveen
Tanager Wealth Management
Wellington Management Company

View all funds holding Candel Therapeutics